Weicong Wang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
First-in-human study to assess the safety, tolerability, and pharmacokinetics of intravenous SHPL-49 following single- and multiple-ascending-dose administration in healthy adults.
Journal: Journal of pharmaceutical and biomedical analysis
Published: February 04, 2024
Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data.
Journal: Translational lung cancer research
Published: November 12, 2023
Human safety study of a selective neuronal adenylate cyclase 1 inhibitor NB001 which relieves the neuropathic pain and blocks ACC in adult mice.
Journal: Molecular pain
Published: March 10, 2022
Pharmacokinetics, pharmacodynamics, safety, tolerability, and mass balance of single and continuous intravenous infusion of SPT-07A in healthy volunteers.
Journal: European journal of clinical pharmacology
Published: December 18, 2019
Development of an LC-MS/MS method for quantifying two main metabolites of abivertinib in human plasma.
Journal: Biomedical chromatography : BMC
Published: March 27, 2019
De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.
Journal: Journal of medicinal chemistry
Published: September 08, 2018
Bioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers.
Journal: Clinical therapeutics
Published: July 03, 2018
Development and validation of a UPLC-MS/MS method for quantification of osimertinib (AZD9291) and its metabolite AZ5104 in human plasma.
Journal: Biomedical chromatography : BMC
Published: June 28, 2018
Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.
Journal: Journal of medicinal chemistry
Published: February 15, 2018
First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of Resistance.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 14, 2017
Development of an UPLC-MS/MS method for quantification of Avitinib (AC0010) and its five metabolites in human cerebrospinal fluid: Application to a study of the blood-brain barrier penetration rate of non-small cell lung cancer patients.
Journal: Journal of pharmaceutical and biomedical analysis
Published: January 26, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026